WASHINGTON - Forty states may have to forfeit millions in federal funds, allocated for the healthcare of low-income children, because they failed to spend the money in the allotted time. $4.2 billion in federal dollars, part of the Children's Health Insurance Program, has not been spent. Unless it was spent by Sept. 30, these funds will be redistributed to the only 10 states that used their full allotments.
California and Texas, which have 29% of the nation's 11 million uninsured children, account for more than half of the unspent money. States that have successfully taken advantage of the program include New York, Alaska, Massachusetts, Missouri, and Pennsylvania.
The Children's Health Insurance Program was designed to help children in families with too much income to qualify for Medicaid and too little income to be able to afford private insurance.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.